Saxenda, also an incretin mimetic, was approved for obesity with the active ingredient liraglutide (and previously approved for type 2 diabetes under the name Victoza) as a daily injection
Results of this in vitro portion of the study demonstrated enhanced bacterial clearance at four hours and 72 hours after topical Glutaryl application
How Injection Site Affects GLP-1 Absorption According to UK product information for GLP-1 receptor agonists, there are no clinically relevant differences in medication exposure between the abdomen, thigh, and upper arm when these medications are administered as directed
Ozempic, an earlier formulation of semaglutide, was approved by the FDA in 2017 for use in patients with diabetes because it lowers blood glucose
The provider will consider the specific compounded formulation, the patients individual response, side effect profile, and overall health status